125 related articles for article (PubMed ID: 16077931)
1. NF-kappaB activation contributes to anthracycline resistance pathway in human ovarian carcinoma cell line A2780.
Salvatore C; Camarda G; Maggi CA; Goso C; Manzini S; Binaschi M
Int J Oncol; 2005 Sep; 27(3):799-806. PubMed ID: 16077931
[TBL] [Abstract][Full Text] [Related]
2. Nuclear factor-kappaB, induced in human carcinoma cell line A2780 by the new anthracycline men 10755, is devoid of transcriptional activity.
Camarda G; Binaschi M; Maggi CA; Goso C
Int J Cancer; 2002 Dec; 102(5):476-82. PubMed ID: 12432549
[TBL] [Abstract][Full Text] [Related]
3. Sabarubicin- (MEN 10755) and paclitaxel show different kinetics in nuclear factor-kappaB (NF-kB) activation: effect of parthenolide on their cytotoxicity.
Bellarosa D; Binaschi M; Maggi CA; Goso C
Anticancer Res; 2005; 25(3B):2119-28. PubMed ID: 16158953
[TBL] [Abstract][Full Text] [Related]
4. Increased cellular accumulation and distribution of amrubicin contribute to its activity in anthracycline-resistant cancer cells.
Mamidipudi V; Shi T; Brady H; Surapaneni S; Chopra R; Aukerman SL; Heise C; Sung V
Cancer Chemother Pharmacol; 2012 Apr; 69(4):965-76. PubMed ID: 22120960
[TBL] [Abstract][Full Text] [Related]
5. Sabarubicin (MEN10755)-induced apoptosis is independent from mtDNA in A2780 human ovarian tumor cells.
Bressan A; Nardelli F; Bellarosa D; Bigioni M; Curcurù G; Curatella B; Crea A; Maggi CA; Manzini S; Binaschi M
Anticancer Res; 2007; 27(6B):4039-46. PubMed ID: 18225568
[TBL] [Abstract][Full Text] [Related]
6. Acquisition of doxorubicin resistance in ovarian carcinoma cells accompanies activation of the NRF2 pathway.
Shim GS; Manandhar S; Shin DH; Kim TH; Kwak MK
Free Radic Biol Med; 2009 Dec; 47(11):1619-31. PubMed ID: 19751820
[TBL] [Abstract][Full Text] [Related]
7. [Chemotherapy resistance induced by interleukin-6 in ovarian cancer cells and its signal transduction pathways].
Wang Y; Li LZ; Ye L; Niu XL; Liu X; Zhu YQ; Sun WJ; Liang YJ
Zhonghua Fu Chan Ke Za Zhi; 2010 Sep; 45(9):691-8. PubMed ID: 21092551
[TBL] [Abstract][Full Text] [Related]
8. A hMTR4-PDIA3P1-miR-125/124-TRAF6 Regulatory Axis and Its Function in NF kappa B Signaling and Chemoresistance.
Xie C; Zhang LZ; Chen ZL; Zhong WJ; Fang JH; Zhu Y; Xiao MH; Guo ZW; Zhao N; He X; Zhuang SM
Hepatology; 2020 May; 71(5):1660-1677. PubMed ID: 31509261
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of TPA-induced growth inhibition and apoptosis in myeloid leukemia cells by BAY 11-7082, an NF-kappaB inhibitor.
Hansson A; Marín YE; Suh J; Rabson AB; Chen S; Huberman E; Chang RL; Conney AH; Zheng X
Int J Oncol; 2005 Oct; 27(4):941-8. PubMed ID: 16142309
[TBL] [Abstract][Full Text] [Related]
10. Autocrine production of interleukin 1beta confers constitutive nuclear factor kappaB activity and chemoresistance in pancreatic carcinoma cell lines.
Arlt A; Vorndamm J; Müerköster S; Yu H; Schmidt WE; Fölsch UR; Schäfer H
Cancer Res; 2002 Feb; 62(3):910-6. PubMed ID: 11830551
[TBL] [Abstract][Full Text] [Related]
11. Reversal of "atypical"-multidrug resistance by recombinant human tumor necrosis factor in the human ovarian cancer cell line A2780-DX3.
Cimoli G; Valenti M; Parodi S; Mazzoni A; De Sessa F; Conte P; Russo P
Oncol Res; 1993; 5(8):311-23. PubMed ID: 8012063
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of the E3-ubiquitin ligase receptor subunit betaTRCP1 relates to constitutive nuclear factor-kappaB activation and chemoresistance in pancreatic carcinoma cells.
Müerköster S; Arlt A; Sipos B; Witt M; Grossmann M; Klöppel G; Kalthoff H; Fölsch UR; Schäfer H
Cancer Res; 2005 Feb; 65(4):1316-24. PubMed ID: 15735017
[TBL] [Abstract][Full Text] [Related]
13. Nuclear Transcription Factor Kappa B Downregulation Reduces Chemoresistance in Bone Marrow-derived Cells Through P-glycoprotein Modulation.
Loaiza B; Hernández-Gutierrez S; Montesinos JJ; Valverde M; Rojas E
Arch Med Res; 2016 Feb; 47(2):78-88. PubMed ID: 27259382
[TBL] [Abstract][Full Text] [Related]
14. Extract of Bryophyllum laetivirens reverses etoposide resistance in human lung A549 cancer cells by downregulation of NF-κB.
Kaewpiboon C; Srisuttee R; Malilas W; Moon J; Kaowinn S; Cho IR; Johnston RN; Assavalapsakul W; Chung YH
Oncol Rep; 2014 Jan; 31(1):161-8. PubMed ID: 24220725
[TBL] [Abstract][Full Text] [Related]
15. Parthenolide reverses doxorubicin resistance in human lung carcinoma A549 cells by attenuating NF-κB activation and HSP70 up-regulation.
Xin Y; Yin F; Qi S; Shen L; Xu Y; Luo L; Lan L; Yin Z
Toxicol Lett; 2013 Aug; 221(2):73-82. PubMed ID: 23792430
[TBL] [Abstract][Full Text] [Related]
16. Phosphoinositide 3-kinase/Akt pathway plays an important role in chemoresistance of gastric cancer cells against etoposide and doxorubicin induced cell death.
Yu HG; Ai YW; Yu LL; Zhou XD; Liu J; Li JH; Xu XM; Liu S; Chen J; Liu F; Qi YL; Deng Q; Cao J; Liu SQ; Luo HS; Yu JP
Int J Cancer; 2008 Jan; 122(2):433-43. PubMed ID: 17935137
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast growth factor-inducible 14 regulates cell growth and multidrug resistance of small-cell lung cancer through the nuclear factor-κB pathway.
Li X; Zhu W; Chen Z; Luo L; Huang J; Zhang F; Li M; Guo Y; Guo L
Anticancer Drugs; 2014 Nov; 25(10):1152-64. PubMed ID: 25054270
[TBL] [Abstract][Full Text] [Related]
18. Reversal of physiological stress-induced resistance to topoisomerase II inhibitors using an inducible phosphorylation site-deficient mutant of I kappa B alpha.
Brandes LM; Lin ZP; Patierno SR; Kennedy KA
Mol Pharmacol; 2001 Sep; 60(3):559-67. PubMed ID: 11502888
[TBL] [Abstract][Full Text] [Related]
19. Nuclear factor-kappaB mediates up-regulation of cathepsin B by doxorubicin in tumor cells.
Bien S; Ritter CA; Gratz M; Sperker B; Sonnemann J; Beck JF; Kroemer HK
Mol Pharmacol; 2004 May; 65(5):1092-102. PubMed ID: 15102937
[TBL] [Abstract][Full Text] [Related]
20. Circumvention of nuclear factor kappaB-induced chemoresistance by cytoplasmic-targeted anthracyclines.
Bilyeu JD; Panta GR; Cavin LG; Barrett CM; Turner EJ; Sweatman TW; Israel M; Lothstein L; Arsura M
Mol Pharmacol; 2004 Apr; 65(4):1038-47. PubMed ID: 15044634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
